DEVELOPMENT OF HIRUDIN AS AN ANTITHROMBOTIC AGENT

被引：137
|
作者：
MARKWARDT, F
机构：
来源：
SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1989年 / 15卷 / 03期
关键词：
D O I：
10.1055/s-2007-1002719
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：269 / 282
页数：14
相关论文
共 50 条
  • [41] An ideal thrombolytic and antithrombotic agent?
    Matsuo, O
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (10) : 2154 - 2155
  • [42] GH9001, a novel antithrombotic agent, is more effective than low-molecular-weight heparin or hirudin in rabbit models.
    Weitz, JI
    Klement, P
    Peng, L
    Stafford, A
    Fredenburgh, J
    Johansen, K
    Hirsh, J
    BLOOD, 2002, 100 (11) : 83A - 83A
  • [43] MONITORING OF THE ANTICOAGULANT AND ANTITHROMBOTIC EFFECTS OF SUBCUTANEOUSLY AND INTRAVENOUSLY ADMINISTERED RECOMBINANT HIRUDIN IN DOGS
    KHENKINA, Y
    KOZA, M
    WALENGA, JM
    FAREED, J
    PIFARRE, R
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1305 - 1305
  • [44] SUSTAINED ANTITHROMBOTIC ACTIVITY AFTER PLASMA-CLEARANCE OF HIRUDIN - COMPARISON WITH HEPARIN
    AGNELLI, G
    PASCUCCI, C
    COSMI, B
    RENGA, C
    NENCI, GG
    HIRSH, J
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 651 - 651
  • [45] MONITORING OF THE ANTICOAGULANT AND ANTITHROMBOTIC EFFECTS OF SUBCUTANEOUSLY AND INTRAVENOUSLY ADMINISTERED RECOMBINANT HIRUDIN IN DOGS
    KHENKINA, Y
    KOZA, MJ
    WALENGA, JM
    FAREED, J
    PIFARRE, R
    FASEB JOURNAL, 1993, 7 (03): : A180 - A180
  • [46] In vivo analysis of antithrombotic effectiveness of recombinant hirudin on microvascular thrombus formation and recanalization
    Roesken, F
    Vollmar, B
    Rücker, M
    Seiffge, D
    Menger, MD
    JOURNAL OF VASCULAR SURGERY, 1998, 28 (03) : 498 - 505
  • [47] The antithrombotic effect of a novel hirudin derivative after reconstruction of carotid artery in rabbits
    Lu, Wei Feng
    Mo, Wei
    Liu, Zhenjie
    Fu, Wei Guo
    Guo, Da Qiao
    Wang, Yu Qi
    Song, Hou Yan
    THROMBOSIS RESEARCH, 2010, 126 (04) : E339 - E343
  • [48] USE OF RECOMBINANT HIRUDIN AS ANTITHROMBOTIC TREATMENT IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA
    SCHIELE, F
    VUILLEMENOT, A
    KRAMARZ, P
    KIEFFER, Y
    ANGUENOT, T
    BERNARD, Y
    BASSAND, JP
    AMERICAN JOURNAL OF HEMATOLOGY, 1995, 50 (01) : 20 - 25
  • [49] OPTIMAL DOSE OF ASPIRIN AS ANTITHROMBOTIC AGENT
    SINZINGER, H
    VIRGOLINI, I
    VINAZZER, A
    FITSCHA, P
    WASINGER, T
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 24 - 24
  • [50] ON THE PROBLEM OF THE APPLICATION OF MICRISTIN AS ANTITHROMBOTIC AGENT
    NORDEN, C
    STEPANAUSKAS, M
    HEINE, H
    DEUTSCHE GESUNDHEITSWESEN-ZEITSCHRIFT FUR KLINISCHE MEDIZIN, 1982, 37 (35): : 1515 - 1520
12345